study on avelumab and axitinib vs sunitinib in the treatment of advanced renal cell carcinoma
Published 5 years ago • 207 plays • Length 9:30Download video MP4
Download video MP3
Similar videos
-
4:39
avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
-
3:22
biomarker analysis from javelin renal 101: avelumab plus axitinib versus sunitinib in arcc
-
0:44
real-world efficacy of avelumab and axitinib in advanced renal cell carcinoma
-
2:27
combining avelumab and axitinib in advanced renal cell carcinoma (rcc)
-
4:48
prof jon haanan on the javelin study
-
0:57
avelumab and axitinib for the treatment of advanced rcc
-
1:45
keynote-426: pembrolizumab and axitinib vs sunitinib in advanced renal cell carcinoma
-
2:32
avelumab plus axitinib improves survival in advanced renal-cell carcinoma patients
-
1:06
dr. mcgregor on the utility of axitinib/avelumab in advanced rcc
-
11:58
checkmate 214: nivolumab ipilimumab or sunitinib in patients with advanced renal cell carcinoma
-
1:24
final results of avelumab and axitinib in rcc in the javelin renal 101 trial
-
1:37
dr. shuch on caveats of avelumab/axitinib combination in rcc
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
3:28
dr rini on a biomarker analysis for pembrolizumab/axitinib in advanced rcc
-
9:23
javelin renal 101: avelumab plus axitinib improve pfs for advanced renal cell cancer
-
5:55
targetting pd-l1 with avelumab in metastatic merkel cell carcinoma
-
15:21
star: first-line sunitinib or pazopanib in the treatment of locally advanced and/or metastatic r...
-
3:09
should sunitinib still be used in the treatment of metstatic kidney cancer?
-
8:11
implications of using adjuvant sorafenib and sunitinib in unfavourable renal carcinoma